Abstract

Scallop mantle (Chlamys Farreri) was hydrolysed with commercially available food-grade mixed proteases. The resulting hydrolysates of scallop protein hydrolyzate contained high levels of Glu, Gly, Asp, Arg, Ala, and Pro, and showed DPPH, hydroxyl radicals scavenging abilities, and reducing power. In this study scallop protein hydrolyzate had angiotensin converting enzyme inhibitory activity in vitro with an IC50 of 10.28 mg/ml. It was also found that oral administration of scallop protein hydrolyzate decreased total serum cholesterol and triglyceride, and increased high-density lipoprotein cholesterol in rats fed with high-fat diet. The above results indicate that scallop protein hydrolyzate may prove to be a promising functional agent for the prevention and treatment of hypertension, hyperlipidaemia, and other cardiovascular diseases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.